Avalo Therapeutics, Inc.
AVTX
$9.88
$0.515.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 113.26M | 125.05M | 134.55M | 81.86M | 93.43M |
| Total Receivables | -- | -- | 611.00K | 998.00K | 33.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.90M | 1.83M | 3.71M | 3.25M | 2.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.00K | 62.00K | 19.00K | 41.00K | -- |
| Total Current Assets | 115.19M | 126.94M | 138.89M | 86.15M | 95.89M |
|
|
|||||
| Total Current Assets | 115.19M | 126.94M | 138.89M | 86.15M | 95.89M |
| Net Property, Plant & Equipment | 686.00K | 949.00K | 1.21M | 1.67M | 1.78M |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 210.00K | 131.00K | 131.00K | 131.00K | 131.00K |
| Total Assets | 126.58M | 138.52M | 150.73M | 98.46M | 108.31M |
|
|
|||||
| Total Accounts Payable | 2.37M | 681.00K | 283.00K | 1.81M | 654.00K |
| Total Accrued Expenses | 5.68M | 3.69M | 5.22M | 3.59M | 3.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 482.00K | 526.00K | 568.00K | 550.00K | 548.00K |
| Total Finance Division Other Current Liabilities | 729.00K | 719.00K | 894.00K | 54.72M | 91.47M |
| Total Other Current Liabilities | 729.00K | 719.00K | 894.00K | 54.72M | 91.47M |
| Total Current Liabilities | 9.26M | 5.62M | 6.96M | 60.67M | 96.40M |
|
|
|||||
| Total Current Liabilities | 9.26M | 5.62M | 6.96M | 60.67M | 96.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 197.00K | 275.00K | 350.00K | 1.08M | 1.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.55M | 10.02M | 10.39M | 13.96M | 12.88M |
| Total Liabilities | 22.01M | 15.91M | 17.70M | 75.72M | 110.46M |
|
|
|||||
| Common Stock & APIC | 508.79M | 506.03M | 503.30M | 356.00M | 344.35M |
| Retained Earnings | -404.18M | -383.41M | -370.26M | -334.92M | -357.96M |
| Treasury Stock & Other | -34.00K | -- | -- | -- | -- |
| Total Common Equity | 104.57M | 122.62M | 133.03M | 21.08M | -13.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 1.66M | 11.46M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 1.66M | 11.46M |
|
|
|||||
| Total Common Equity | 104.57M | 122.62M | 133.03M | 21.08M | -13.61M |
| Total Preferred Equity | -- | -- | -- | 1.66M | 11.46M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 104.57M | 122.62M | 133.03M | 22.73M | -2.15M |
|
|
|||||